30 devices · GMDN 53233
Conjugated (direct) bilirubin IVD kits use spectrophotometry to measure levels of this specific form of bilirubin in blood or other clinical specimens. These tests help diagnose and monitor conditions like biliary obstruction, liver disease, or hemolytic disorders by distinguishing direct bilirubin from indirect forms, which require different clinical approaches.
These kits are typically sold as reagent-based systems requiring calibration and maintenance per manufacturer instructions. They’re regulated as in vitro diagnostic devices, with compliance requirements varying by jurisdiction, though classification (e.g., risk level) is determined per device and market. Availability depends on local regulatory approvals and healthcare provider preferences for testing workflows.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.